US Corporate Distress Financial Stress SEC Filings — January 28, 2026

29-01-2026

MINERALRITE Corp filed a Form 8-K on 2026-01-29 disclosing entry into a Material Definitive Agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details regarding the agreement, transaction value, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no period-over-period comparisons or named entities beyond the company itself provided.

29-01-2026

Agape ATP Corp filed a Form 8-K on 2026-01-29 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, transaction values, guidance changes, or other details provided. This event signals significant regulatory or compliance issues with the listing exchange.

29-01-2026

SYNLOGIC, INC. filed a Form 8-K on 2026-01-29 under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 8.01 reports other events. No financial metrics, quantitative data, reasons for delisting, or further details are disclosed.

• ·AccNo: 0001193125-26-028333
• ·File Size: 173 KB
• ·Sector: not specified

29-01-2026

VSE Corp filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific transaction values, financial metrics, period-over-period changes, or quantitative impacts are disclosed in the provided filing summary. This combination of items indicates multiple potentially material developments, but lacks details for directional assessment.

29-01-2026

Runway Growth Finance Corp. filed an 8-K on January 29, 2026, under Item 1.01 announcing entry into a material definitive agreement and under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, or impacts are disclosed.

29-01-2026

AI Technology Group Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details regarding the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are disclosed. This represents a mandatory disclosure of a material event with no quantitative metrics or directional performance indicators provided.

29-01-2026

MGE Energy Inc filed an 8-K on January 29, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No details on the agreement's nature, parties, dollar value, strategic role, or financial impacts are provided.

29-01-2026

MUNCY COLUMBIA FINANCIAL Corp filed an 8-K on January 29, 2026 (AccNo: 0001174947-26-000109, Size: 359 KB), disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific terms, financial impacts, or quantitative details about the agreement are provided in the filing summary. This is a mandatory multi-item disclosure without directional metrics.

• ·AccNo: 0001174947-26-000109
• ·Filing Size: 359 KB

29-01-2026

NEONC Technologies Holdings, Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits listed under Item 9.01. This is a multi-item mandatory disclosure, but specific details on the agreement, transaction size, share counts, financial terms, or impacts are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or strategic context provided.

29-01-2026

IMA Tech filed a Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.07 submission of matters to a vote of security holders. Item 9.01 lists financial statements and exhibits. No specific details, financial metrics, transaction values, vote outcomes, or other quantitative data are provided in the filing summary.

29-01-2026

The filer submitted an 8-K on 2026-01-29 (AccNo: 0001193125-26-029136) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This multi-item filing signals potentially significant contractual and financial commitments, but no specific transaction details, dollar values, parties, terms, or impacts are disclosed in the provided information. No quantitative metrics, period-over-period changes, or qualitative strategic context are available.

29-01-2026

Unitil Corp filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-029469), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement terms, parties, dollar value, strategic rationale, or financial impacts are disclosed. This appears to be a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

29-01-2026

Velocity Financial, Inc. filed an 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative performance metrics.

29-01-2026

Advanced Flower Capital Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No transaction details, dollar values, financial impacts, or performance metrics are provided.

29-01-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 29, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction values, share counts, financial metrics, dollar amounts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant corporate actions but lacks quantitative details for impact assessment.

29-01-2026

Seaport Entertainment Group Inc. filed an 8-K on January 29, 2026 (AccNo: 0001104659-26-007556), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, terms, financial impacts, or quantitative metrics are disclosed in the available information. No positive or negative metrics, comparisons, or scheduled events mentioned.

29-01-2026

Revelation Biosciences, Inc. filed a multi-item Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 3.03 material modifications to rights of security holders, with exhibits under Item 9.01. These disclosures signal a strategic transaction potentially positive for operations or funding, however, the equity sales and rights modifications raise dilution risks for existing shareholders. Specific transaction details, dollar values, share counts, and financial impacts are NOT_DISCLOSED.

29-01-2026

Beam Global filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details regarding the agreement's terms, counterparties, dollar value, or financial impacts are disclosed. No quantitative metrics, period-over-period comparisons, positive or negative changes, or guidance revisions are mentioned.

• ·Filing Accession No: 0001437749-26-002333
• ·Filing size: 31 KB
• ·Sector: not specified

29-01-2026

Eagle Materials Inc filed a Form 8-K on January 29, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits, likely a press release with earnings details. No specific revenue, earnings, margins, comparisons, or other metrics are provided in the filing summary.

29-01-2026

Prosperity Bancshares Inc filed an 8-K on January 29, 2026 (AccNo: 0001193125-26-028154), disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction size, financial impacts, or other metrics are provided. This is a multi-item mandatory filing with no positive or negative performance metrics disclosed.

29-01-2026

AMC Entertainment Holdings, Inc. filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), and unregistered sales of equity securities (Item 3.02), with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or dollar values are disclosed. The filing provides limited directional information, with potential positive implications from the agreement offset by possible dilution from equity sales.

29-01-2026

USA Rare Earth, Inc. filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

29-01-2026

Stellar Bancorp, Inc. filed an 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01, with Item 9.01 disclosing financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This represents a mandatory disclosure of a material event, but lacks quantitative data for impact assessment.

29-01-2026

PSQ Holdings, Inc. filed a Form 8-K on January 29, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, named entities, or quantitative data are disclosed in the provided filing summary. This multi-item filing signals significant corporate developments but lacks details for impact assessment.

• ·Multi-item 8-K filing (Items 1.01, 3.03, 5.02, 7.01, 9.01)
• ·AccNo: 0001104659-26-007714
• ·File size: 266 KB

29-01-2026

Allarity Therapeutics, Inc. filed an 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, or performance metrics are provided.

29-01-2026

StandardAero, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-029335), disclosing under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. No financial metrics, transaction values, or performance comparisons are mentioned.

• ·File size: 516 KB

29-01-2026

Trulieve Cannabis Corp. filed a Form 8-K on 2026-01-29 reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, financial obligation, transaction value, strategic context, or any quantitative metrics such as dollar amounts, percentages, or impacts are disclosed in the provided filing summary.

29-01-2026

KADANT INC filed a Form 8-K on 2026-01-29 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, financial metrics, or performance comparisons provided. No positive or negative quantitative impacts are disclosed.

• ·AccNo: 0000886346-26-000005
• ·File size: 184 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Cheetah Net Supply Chain Service Inc. filed a Form 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits attached under Item 9.01. No specific details on the agreement terms, transaction values, share counts, financial impacts, or other metrics were provided in the filing summary.

29-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on 2026-01-29 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed.

29-01-2026

Crypto Co filed an 8-K on January 29, 2026 (AccNo: 0001493152-26-004226), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities, with exhibits under Item 9.01. This is a multi-item mandatory disclosure, but specific details on the agreement, equity sales terms, transaction value, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

29-01-2026

AmBase Corp filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's parties, terms, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a mandatory multi-item disclosure of a potentially significant event, but lacks quantitative metrics or period-over-period comparisons.

• ·AccNo: 0001140361-26-002808
• ·File Size: 189 KB
• ·Sector: NOT_DISCLOSED

29-01-2026

Aprea Therapeutics, Inc. filed an 8-K on January 29, 2026, reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative details on transaction values, financial impacts, or performance metrics provided. No positive or negative metrics, period-over-period comparisons, or balance sheet effects are disclosed.

29-01-2026

Labcorp Holdings Inc. filed a Form 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or dollar values are provided in the filing summary.

29-01-2026

Old National Bancorp (/IN/) filed an 8-K on January 29, 2026 (AccNo: 0001104659-26-007980), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial impacts are provided in the filing summary.

29-01-2026

Gentherm Inc filed an 8-K on 2026-01-29 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing information.

29-01-2026

zSpace, Inc. filed a multi-item Form 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, with exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts were disclosed. This combination suggests potential strategic changes alongside possible dilution risks, but lacks specifics for directional assessment.

29-01-2026

Super Micro Computer, Inc. filed an 8-K on January 29, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction value, parties involved, financial impacts, or contents of the exhibits are disclosed in the provided filing information. This represents a mandatory disclosure of a material event with no quantitative metrics or directional indicators provided.

29-01-2026

Arq, Inc. filed an 8-K on 2026-01-29 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or metrics are provided in the filing summary. This represents a multi-item informational filing with no quantified positive or negative metrics disclosed.

29-01-2026

urban-gro, Inc. filed an 8-K on 2026-01-29 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No transaction values, share counts, financial metrics, or other quantitative details are disclosed in the provided filing summary. This multi-item mandatory disclosure signals a potentially strategic transaction but introduces dilution risk from equity sales.

29-01-2026

Oncotelic Therapeutics, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001493152-26-004237), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing, timely submitted on the event date, but no specific transaction details, dollar values, terms, or financial metrics are disclosed in the provided information. Implications include potential dilution and increased obligations, but lack of quantification prevents directional assessment.

29-01-2026

Sono Group N.V. filed a Form 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01, which may indicate strategic advancements such as financing or partnerships. However, the filing also reports unregistered sales of equity securities under Item 3.02, introducing potential shareholder dilution risk. Financial statements and exhibits are provided under Item 9.01, but specific transaction details, values, or impacts are NOT_DISCLOSED.

29-01-2026

Calumet, Inc. filed a Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or performance metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no specified positive or negative metrics.

29-01-2026

Dare Bioscience, Inc. filed a Form 8-K on January 29, 2026, reporting under Item 3.02 unregistered sales of equity securities, Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing indicates governance changes and potential capital raising activities without specified positive or negative metrics.

29-01-2026

Modine Manufacturing Co filed an 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, disclosures, financial metrics, positive or negative changes, or transaction values are provided in the filing summary. All quantitative and qualitative impacts are NOT_DISCLOSED.

29-01-2026

Bain Capital Specialty Finance, Inc. filed an 8-K on 2026-01-29 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative transaction details, financial metrics, or impacts are provided in the filing summary.